Skip to main content
Livermore
Livermore
ZHEN

Engineers Gate Manager LP

SEC CIK
0001620220
Latest filing
Aug 14, 2026

ACAD holding history

Acadia Pharmaceuticals Inc in every 13F filed by Engineers Gate Manager LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACAD overviewAll 13F holders of ACADFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of ACAD by Engineers Gate Manager LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−66,032−100.0%Sold outHolders
Q1 202666,032$1.47M<0.1%−7,808−10.6%ReducedHolders
Q4 202573,840$1.97M<0.1%+14,319+24.1%AddedHolders
Q3 202559,521$1.27M<0.1%+19,376+48.3%AddedHolders
Q2 202540,145$865.9K<0.1%−58,759−59.4%ReducedHolders
Q1 202598,904$1.64M<0.1%−1,044−1.0%ReducedHolders
Q4 202499,948$1.83M<0.1%−33,246−25.0%ReducedHolders
Q3 2024133,194$2.05M<0.1%+25,449+23.6%AddedHolders
Q2 2024107,745$1.75M<0.1%−96,928−47.4%ReducedHolders
Q1 2024204,673$3.78M0.1%+204,673NewHolders
Q4 20230$00.0%−142,241−100.0%Sold outHolders
Q3 2023142,241$2.96M0.1%+76,880+117.6%AddedHolders
Q2 202365,361$1.57M0.1%−11,249−14.7%ReducedHolders
Q1 202376,610$1.44M0.1%+57,530+301.5%AddedHolders
Q4 202219,080$303.8K<0.1%−16,175−45.9%ReducedHolders
Q3 202235,255$577.0K<0.1%+2,568+7.9%AddedHolders
Q2 202232,687$461.0K<0.1%+32,687NewHolders
Q1 20220$00.0%−24,319−100.0%Sold outHolders
Q4 202124,319$568.0K<0.1%+24,319NewHolders
Q3 20210$00.0%−11,030−100.0%Sold outHolders
Q2 202111,030$269.0K<0.1%−29,845−73.0%ReducedHolders
Q1 202140,875$1.05M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.